A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia
Stopped Study terminated early, main goals achieved
Conditions
Interventions
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.